Metabotropic glutamate receptors : Potential pharmacological targets in Parkinson's disease treatment

5th International Meeting on Metabotropic Glutamate Receptors, Taormina, ITALY, SEP 18-23, 2005International audienceno abstrac

Injections of the group III metabotropic glutamate receptor selective agonist ACPT-I in the globus pallidus reduces reaction time and cataleptic deficits in Parkinsonian rats

5th International Meeting on Metabotropic Glutamate Receptors, Taormina, ITALY, SEP 18-23, 2005International audienceno abstrac

Functional interactions between metabotropic glutamate and adenosine A2A receptors in parkinsonian rats

Workshop of the European-Behavioural-Pharmacology-Society on Neurodegeneration - Basic Mechanisms of Motor and Cognitive Dysfunctions, Cracow, POLAND, SEP 02-04, 2006International audienceno abstrac

Interaction between metabotropic glutamate and adenosine A2A receptor antagonists ASA potent anti-parkinsonian treatment

11th Biennial Meeting of the European-Behavioral-Pharmacology-Society, Barcelona, SPAIN, SEP 09-12, 2005International audienceno abstrac

Group III metabotropic glutamate receptor subtypes differentially regulate motor function in parkinsonian rats

12th Biennial Meeting of the European-Pharmacology-Society, Tubingen, GERMANY, AUG 31-SEP 03, 2007International audienceno abstrac

Opposite effects of group III metabotropic glutamate receptors activation in the globus pallidus or the substantia nigra pars reticulata in regulating motor control in Parkinsonian rats.

Workshop of the European-Behavioural-Pharmacology-Society on Neurodegeneration - Basic Mechanisms of Motor and Cognitive Dysfunctions, Cracow, POLAND, SEP 02-04, 2006International audienceno abstrac

MODULATION OF POTASSIUM KCA2 CHANNELS AS AN ANTIPARKINSONIAN STRATEGY

14th Biennial Meeting of the European-Behavioural-Pharmacology-Society, Amsterdam, NETHERLANDS, AUG 26-29, 2011International audienceno abstrac